SASB

Home > SASB > Medicine supply chain integrity > HC-DR-250a.2

Data pertaining to 2025

Overview Retail energy management Controlled substances management Medicine supply chain integrity Activity metrics Patient health outcomes Data security and privacy

Medicine supply chain integrity

GRI HC-DR-250a.2

Number of drug recalls issued, Total units recalled, Percentage for private-label products

In 2025, there were 38 drug recalls, including 2 involving own-brands and 36 involving other suppliers. The company does not consolidate the total number of units collected in these processes.